Kratom use is difficult to measure by name alone
Kratom comes from the plant Mitragyna speciosa and contains compounds that can affect opioid receptors and other systems. People may use it for pain, mood, energy, or self-treatment of opioid withdrawal, but repeated use can lead to tolerance, withdrawal, impaired control, and other harms. Powders, capsules, teas, and concentrated extracts may deliver very different amounts of active compounds. Record the brand, serving size, frequency, and reason for each use so the clinician can understand exposure more accurately.
Why treatment does not follow one standard protocol
Research on treatment for kratom use disorder is limited, and there is no FDA-approved medication specifically for it. Clinicians may use established substance use treatment principles and, in selected cases, consider approaches informed by opioid use disorder care, but the evidence is not strong enough for one standard protocol. Published evidence is not sufficient to promise that one taper, medication, or detoxification schedule works for everyone. A responsible clinician explains the uncertainty, monitors response, and changes the plan when symptoms or risks shift.
Assessment should include the reason kratom was started
Assessment should document the product, amount, frequency, extracts or concentrates, other substances, withdrawal symptoms, pain, mental health, and prior opioid use. Care may include a monitored reduction plan, symptom management, behavioral treatment, recovery support, and treatment for another substance use disorder when present. Pain, fatigue, mood symptoms, and attempts to avoid opioid withdrawal may each require a different parallel plan. Ignoring the original problem can make a return to kratom or another substance more likely after the first reduction.
Product uncertainty belongs in the safety plan
Kratom products are not uniform, and labels may not accurately describe strength or contaminants. Seek urgent care for seizures, severe confusion, unresponsiveness, trouble breathing, chest pain, or suspected overdose, and tell emergency clinicians exactly what products and other substances may have been used. Do not assume that two packages with similar labels have the same strength or contents. Combining kratom with opioids, sedatives, alcohol, or other medicines should be disclosed because the mixture can change both symptoms and emergency decisions.
Choose a clinician who works across specialties
Ask whether the clinician has experience with kratom and can coordinate addiction medicine, pain care, mental health treatment, and laboratory evaluation when indicated. Avoid anyone who guarantees a rapid cure, sells an undisclosed detoxification product, or advises replacing kratom with an unmonitored sedative or opioid. The best fit may involve addiction medicine plus pain, psychiatric, or primary care rather than a stand-alone detoxification seller. Ask who will manage each condition and how the clinicians will share a single medication list.
Prepare a usable record before the visit
Bring packaging or photographs, an honest use log, and a complete medication list to a healthcare visit. If kratom was being used to manage opioid withdrawal or cravings, request a formal evaluation for opioid use disorder and discuss approved treatment rather than returning to unregulated products. Keep several days of notes on timing, amount, withdrawal, sleep, pain, and other substances without increasing use to test a pattern. Bring the actual package when safe, since a product name copied from memory may omit important details.
Warning signs of an unreliable kratom program
Be cautious when a service guarantees a painless withdrawal or refuses to identify the ingredients in products it sells. A credible provider should discuss evidence limits and give clear instructions for urgent symptoms. It should also screen for opioid use disorder instead of assuming kratom is the only issue. Treatment costs, follow-up, and the clinician responsible for prescribing should be stated before payment.